NHLBI single-site investigator-initiated clinical trials (R61/R33)
This NHLBI funding opportunity supports investigator-initiated single-site Phase II+ clinical trials using a two-phase, milestone-driven R61 (up to 1 year) → R33 (up to 4 years) mechanism. The R61 funds start-up activities (protocol finalization, manuals/CRFs, IRB/DSMB setup, partnerships, and IND/IDE confirmation if needed), and progression to the R33 full-enrollment phase requires meeting ag…
This NOFO supports applications to develop and implement investigator-initiated single-site clinical trials. Clinical trials supported by this NOFO include Phase II and above clinical trials. This NOFO is applicable to single-site clinical trials only, and will utilize a bi-phasic (R61/R33), mil…
Funding Source
Eligibility
- Foreign entities: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Required registrations …
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers